Dabur India, a prominent player in the spice industry, reaffirmed its commitment to regulatory compliance, asserting that all its spice products adhere to the standards established by the Food Safety and Standards Authority of India (FSSAI) for the Indian market. CEO Mohit Malhotra emphasized the company’s compliance not only with FSSAI regulations but also with the guidelines set by the Spice Board of India for overseas markets.
Malhotra highlighted the rigorous testing procedures undertaken for export consignments, ensuring adherence to regulatory specifications. He underscored the company’s reliance on steam sterilization for export batches and the establishment of an in-house microlab for thorough microbial testing of all spice batches.
Dabur’s assurance of compliance follows recent regulatory actions in international markets, including the suspension of sales of certain spice blends by other Indian brands in Hong Kong and recalls mandated by Singapore due to contamination concerns.
The heightened scrutiny by international regulatory bodies has prompted Indian authorities, including the FSSAI, to intensify quality assessments of spice manufacturers like MDH and Everest, which are popular both domestically and internationally.
The United States Food and Drug Administration (FDA) has also initiated investigations into the matter, underscoring the global implications of ensuring the safety and quality of spice products.
In response to these developments, Indian authorities have conducted inspections at the production facilities of MDH and Everest, reflecting the concerted efforts to uphold food safety standards and protect consumer health both domestically and internationally.